BioScience Health Innovations (BHIC) Common Equity (2019 - 2025)
Historic Common Equity for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to $1.7 million.
- BioScience Health Innovations' Common Equity rose 36206.82% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 36206.82%. This contributed to the annual value of $835240.0 for FY2024, which is 1245562.13% up from last year.
- Latest data reveals that BioScience Health Innovations reported Common Equity of $1.7 million as of Q3 2025, which was up 36206.82% from $1.7 million recorded in Q2 2025.
- BioScience Health Innovations' Common Equity's 5-year high stood at $1.7 million during Q2 2025, with a 5-year trough of -$88990.0 in Q1 2023.
- In the last 5 years, BioScience Health Innovations' Common Equity had a median value of $25476.0 in 2022 and averaged $326854.4.
- Per our database at Business Quant, BioScience Health Innovations' Common Equity plummeted by 2077692.31% in 2021 and then surged by 1245562.13% in 2024.
- BioScience Health Innovations' Common Equity (Quarter) stood at $73119.0 in 2021, then plummeted by 65.16% to $25476.0 in 2022, then crashed by 126.53% to -$6760.0 in 2023, then soared by 12455.62% to $835240.0 in 2024, then soared by 104.85% to $1.7 million in 2025.
- Its Common Equity stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.3 million for Q1 2025.